Mallika Nanduri Bhatt

Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as pandemic preparedness and RSV Federally-funded public drug plans, including the Non-Insured Health Benefits program, Canadian Armed Forces Drug Benefit List and veteran programs, with respect to reimbursement for drug products for beneficiaries Canada's Drug Agency policies and processes as it relates to reimbursement recommendation decision-making process and framework Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry Establish accountability with Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance, as well as Regulations, policies and programs related to the review and reimbursement processes Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Engagement with the Government regarding the Strategic Response Fund (SRF) (previously known as SIF) and investment in Canada Annual federal Budgets and Budget updates relating to the biopharmaceutical industry. Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits.

Assist BCAFN in arranging meetings with key decision-makers on BC First Nation community priorities including housing and community infrastructure, justice and policing, fisheries, environmental conservation and climate change.

Advocate for changes to facilitate adoption of auto features for retirement savings. Advocate for legislative or regulatory changes to allow for automatic features in workplace pension plans. Discussions related to the implementation of CRA Notice 344 Consultation on the National Strategy on mental health of men and boys Discussions related to Bill S-5 Connected Care for Canadians Act. FCAC direction to update complaint-handling information for insurers Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB) Discussions related to supply and shortages of drugs in Canada, including the Multi-Stakeholder Steering Committee. Discussions related to regulatory burden, including “cutting red tape”. Impacts on Canadian insurers of proposed U.S. tax measures. Discussions relating to the efficiency and effectiveness of the financial sector regulatory system as it pertains to insurance companies. Discussing plans on the Data Collection Modernization initiative Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs) Statutory review of the Insurance Companies Act as it relates to insurance products and investments. Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Promotion of pension products, including decumulation solutions. Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services. Inter-provincial harmonization and trade barriers as it relates to insurance products. Discussions related to the financial sector policy review. Office of the Superintendent of Financial Institutions (OSFI). Guidelines related to risk management, capital and accounting for insurance companies. This includes capital charges for infrastructure investments under the LICAT. International Trade with respect to opening trade relations, regulations, foreign ownership and national treatment in foreign markets, with regards to India, Europe, China, Japan, Trans-Pacific partnership (TPP), Canada-United States-Mexico Agreement (CUSMA), Plurilateral Trade In Services Agreement (TISA) and the World Trade Organization (WTO). Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage. Promotion of risk-based and principles-based regulation for financial institutions regulations. Personal Information Protection and Electronic Documents Act: seeking workable approaches to privacy rules affecting life and health insurers when the Act is updated. Income Tax Regulations (section 6(1)(f) as it relates to income tax withholding on wage loss replacement plans (disability income benefits). Income Tax Regulations, Part XIV. Income Tax Regulations, Part III: Updating income tax rules for life insurance policies. Income Tax Act, Section 146: Retirement income recommendations regarding the treatment of life insurance companies; Section 146.2 (TFSAs); Section 146.3 (RRIFs). Income Tax Act, Part VI as it relates to capital tax on financial institutions. Financing infrastructure projects, as it relates to investments by insurers Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) risk-based guidance as it relates to life insurance Employment Insurance (EI) reform as it relates to disability benefits; and EI Premium Reduction Program issues. Amendments to Proceeds of Crime (Money Laundering) and Terrorist Financing rules as they affect insurance companies

Raise awareness about the First Nations Bank of Canada; seek opportunities for economic development.

The First Nations Fiscal Management Act, Section 141 Monetizing annual federal infrastructure grants to First Nations to securitize First Nation Finance Authority (FNFA) debentures.

Seeking funding for the establishment and scale-up of the First Nations Procurement Authority (FNPA) to enhance Indigenous business certification and procurement participation. Seeking funding to support digital and in-person services for Indigenous entrepreneurs through the national expansion of the Indigenous Business Centre of Excellence. Seeking funding to scale Indigenous-led tourism development through the delivery of the Signature Indigenous Tourism Experiences Stream and related initiatives. Seeking funding to advance Indigenous housing finance solutions through support for the Yänonhchia’ model, enabling access to homeownership in First Nations communities. Seeking stable funding and access to capital (loan program) from the government to support Indigenous Financial Institutions (IFIs), as well as women and youth entrepreneurial programs across Canada.

Engage with government officials to advance policy changes that streamline and improve the development approval process, while also promoting reforms that support a stronger, healthier development industry in Canada.

Seeking funding to allow for the promotion of the Trail to Canadians and visitors. Seeking funding to maintain and improve The Great Trail. Continued access for the Trail through national parks. Contributing to the development of a National Trails Strategy.

National parks - in relation to Mountain Parks Management plans, integrity of wildlife areas and connectivity between Federal Budget in relation to wildlife crossing structures. new protected areas and Indigenous Protected and Conserved Areas (IPCAs) Creating a pathway and supporting Indigenous leadership in conservation to increase protected and connected areas in relation to advancing Canada's commitment to protect 30% of its lands and waters by 2030. Connecting the landscape to restore movement and address climate change by advancing work that ensures more wildlife crossing structures are built both within Canada and in key transboundary locations between Canada and the U.S. Climate Change Policy in relation to the importance of intact nature as a solution to climate change Biodiversity Loss - in relation to Canada's commitments under the Global Biodiversity Framework and creation and implementation of its National Biodiversity Action Plan